Financials

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Financials — What the Numbers Say

1. Financials in One Page

Repro is a small Indian print-services business whose top line has gone nowhere in twelve years (FY2014 $70M → TTM $51M) and whose earnings power has structurally rebased lower since COVID. Operating margin spent FY2014–FY2020 around 11–16%, collapsed to negative in FY2021, partly recovered to 11% in FY2024, and has now slipped to 7% on a TTM basis as wage and energy costs reset. Cash conversion is the cleanest part of the story — working-capital days have improved from 184 (FY2021) to 50 (FY2025) — but operating cash flow is now being fully absorbed by a fresh capex cycle (CWIP plus fixed-asset additions of ~$17M over 18 months for the Print-on-Demand build-out), so free cash flow has flipped negative for two straight years. The balance sheet is re-leveraging: borrowings have moved $5.9M → $11.6M → $14.3M in eighteen months and ICRA revised its outlook to Negative on 29-Apr-2026. The market cap of $58M puts the stock on 1.15× book and roughly 17× TTM EBITDA, with no reported earnings to anchor a P/E. The single financial metric that matters most right now is operating margin — anything below 9% leaves no cushion for D&A, interest and the FY2026 capex bill.

2. Revenue, Margins, and Earnings Power

A small print-services company with a structural margin reset. The first chart frames the revenue collapse around COVID and the partial post-2022 recovery. The second shows the margin profile that defines whether earnings power has been restored.

The pre-2020 business ran a 12% steady-state operating margin on ~$45–58M of revenue. FY2018's net profit of $2.5M is misleading — operating profit was just $2.1M that year, and the print bottom line was rescued by $4.3M of "other income" (a one-time non-operating gain). FY2021 then wiped out 70% of the revenue base when schools shut. Since FY2023 the company has clawed revenue back to a higher peak, but the FY2024 11% margin has now compressed to 7% on TTM — a worse exit rate than FY2020 — and net profit is back in the red.

The recent quarterly view shows the current trajectory clearly:

Two things matter in this picture. First, the operating margin stepped down by ~3 percentage points in 1Q25 (Jun-2024) and has not recovered since — that is a structural rebase, not a single bad quarter. Second, the most recent quarter (3Q26 / Dec-2025) shows a tentative improvement to 8.0% on a record revenue print of $14.5M, but it remains 3 points below the FY2024 run-rate. Earnings power is not back to where it was eighteen months ago.

3. Cash Flow and Earnings Quality

Free Cash Flow is what the company generates from its operations after paying for the capital expenditure required to keep the business running and growing. It is the single best test of whether reported profits are real.

The operating cash flow line is healthier than the income line — Repro reliably converts D&A back into cash because the printing-press depreciation charge (~$3.6M/yr) does not require matching cash outflow. But that is no longer the binding question. The binding question is capex. FY2024 and FY2025 saw cumulative ~$13.7M of investing outflow against ~$9M of operating cash, producing aggregate FCF of −$4.7M. CWIP went from $1.3M (Mar-2023) to $6.0M (Mar-2024), then back down to $1.0M at Sep-2025 even as gross fixed assets jumped from $26.9M to $39.5M — capitalization onto the balance sheet, not retirement. This is a self-funded growth bet on the Print-on-Demand platform, paid for with debt, while operating margins are simultaneously rebasing.

A second cash-flow distortion deserves a flag. Q2 FY2026 (Sep-2025) reported a net loss of $2.3M driven almost entirely by a −$2.0M "other income" line — i.e. a one-time charge or impairment booked through non-operating income. Operating profit that quarter was a positive $0.85M. Until management discloses the underlying nature, this should be treated as a one-off, but it is the kind of charge that bears scrutiny when it lands in the same year as a leverage step-up.

4. Balance Sheet and Financial Resilience

Borrowings have tripled since March 2024, from $5.9M to $14.3M at Sep-2025. Total debt to operating-EBITDA has moved 0.9× → 2.9× → 3.8×, and interest cover has compressed from 5.4× to 3.8×. ICRA reaffirmed the issuer rating at [BBB+]/[A2] on 29-Apr-2026 but revised the outlook to Negative on the $19M facilities pool, citing the leverage step-up and weaker profitability (PAT/Operating Income: +2.5% FY24 → −0.4% FY25 → −6.2% nine-month FY26).

The offsetting positives are real but secondary:

• Working-capital days have improved from 56 (FY2024) to 29 (FY2025); cash-conversion cycle from 58 days to 50 days.
• Reserves stand at $38.4M (Sep-2025), still ~3× borrowings.
• No external goodwill or intangibles overhang.

But the printing business is capital-intensive and operationally levered; with EBITDA at ~$3.5M (TTM) the company has very little margin for execution slippage on the PoD ramp. A second consecutive year of negative FCF combined with sub-9% operating margin would push net debt / EBITDA above 4× and likely force a further credit-rating action. That is the resilience question.

5. Returns, Reinvestment, and Capital Allocation

Returns are the central problem. ROCE has averaged 4% over five years and ROE has averaged barely 1% — both well below the 12–14% level a competent industrial business should clear. The PoD reinvestment thesis only works if returns on the new fixed assets clear at least the cost of debt (~9% pre-tax in India). They do not yet.

Capital allocation is single-purpose: everything goes into capex. No dividend has been paid since FY2016. No buyback has been executed despite the stock trading near book value. Borrowings have funded most of the recent $13.7M investing programme. Per-share book value sits at $2.66 versus a market price of $4.04 (in dollar-equivalent terms at current FX), so the equity is being asked to fund growth with no return-of-capital optionality. Until ROCE clears the cost of debt, every additional dollar of fixed-asset growth is value-destructive on paper, regardless of whether revenue grows.

6. Segment and Unit Economics

Repro does not publish a segment break-out in the structured financial data available here. From the company description and prior-agent research, the business has three layers — traditional offset (educational books for publishers), digital printing, and a growing Print-on-Demand (PoD) platform — but none is reported separately in the income or balance-sheet files. The recent capex cycle is overwhelmingly directed at the PoD build-out, which means the company-level operating margin compression is in part a product mix shift: high-utilisation offset has been steady-state while PoD is in pre-scale investment mode, dragging the consolidated margin until the new capacity fills.

Without a disclosed segment P&L, an investor cannot yet judge whether the PoD economics are working. Watching consolidated operating margin and ROCE is the only proxy until management provides segment data.

7. Valuation and Market Expectations

The most honest valuation framing for a money-losing small-cap that just stepped up capex is price-to-book + EV/EBITDA + a reality check on what trough multiples look like.

The stock at $4.04 trades:

• 1.52× book — above the 5-year median (~1.0×) but below the FY2024 high of ~1.9×.
• ~17× TTM EV/EBITDA — below its own 3-year average of ~29× because the market is pricing in either margin recovery or the implicit balance-sheet support (reserves of $38.4M against $14.3M debt).
• No P/E — the company is loss-making on a TTM basis, so equity-yield framing is meaningless.

The bear case (sub-7% margin sustained, EBITDA stuck at TTM level, 8× multiple) implies ~$1.16/share. The base case (margin recovery to 10–11% as PoD scales, EBITDA back to $5.6M, 12× multiple) implies ~$3.70/share — close to where the stock trades today. The bull case (PoD pricing power lifts margins to FY2014-style 16%, EBITDA $7.8M, 14× multiple) supports $6.50+/share. The current price is roughly the base case. Buying here means buying the margin-recovery thesis at par — the market is not giving the bull skew for free, and there is no meaningful margin of safety on the bear leg.

8. Peer Financial Comparison

Five Indian listed peers anchor REPRO against the educational-publishing economics (Navneet, S Chand) and the legacy offset/newsprint cost structure (DB Corp, Jagran, HT Media). All figures are TTM as of May 2026 from Screener.in consolidated.

The peer table is unflattering. REPRO has the lowest EBITDA margin (6.9%) and the worst returns on capital (ROE −0.5%, ROCE 1.6%) of the five working comparables, yet trades at the second-highest P/B (1.52×) — well above S Chand (0.67×), Jagran (0.75×) and HT Media (0.32×), which all generate higher absolute earnings than REPRO does. The true closest peer on economics, Navneet Education, earns 12.6% ROE on 17% margins and trades at 1.68× P/B — Navneet's premium is justified by 7× the absolute earnings. REPRO's premium is not. Pay 1.5× book for a 1.6% ROCE business, and you are explicitly buying margin-recovery optionality with no peer-validated discount cushion.

9. What to Watch in the Financials

The financials confirm three things: (1) Repro's pre-COVID earnings power was real but small ($5–6M operating profit at 11% margins); (2) working-capital discipline has improved meaningfully since FY2021; (3) the balance sheet is still solid in book-value terms with reserves of $38.4M against $14.3M of debt. They contradict the cleanest version of the bull case in three ways: (1) operating margin has rebased lower, not back to historical norms; (2) returns on capital are well below the cost of debt, so the new capex is destroying economic value at the margin until proven otherwise; (3) the balance sheet is re-leveraging fast enough to draw a Negative outlook from ICRA.

The first financial metric to watch is operating margin in Q4 FY2026 (Mar-2026 quarter). If it prints at or above 10% — closer to the FY2024 run-rate — the margin compression of the last six quarters can be argued as transitional and the PoD reinvestment story buys credibility. If it prints below 8%, the structural rebase becomes the working assumption, the credit rating likely drifts lower, and the 1.5× P/B premium is not defensible against the peer set.